MarketCap
Facebook
X
TelegramOxford Immunotec Global PLC ROE Ratio | OXFD
Annual ROE Ratio Oxford Immunotec Global PLC
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| - | -0.85 | 56.44 | -37.53 | -30.63 | -26.41 | -36.59 | -10.73 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 56.44 | -37.53 | -12.33 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K |  USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B |  Niderland |
 |
Centogene N.V.
CNTG
|
140.54 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 280.05 | 0.13 % | $ 13.9 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 234.4 | 0.08 % | $ 26 B | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 1.58 | 3.18 % | $ 3.63 M | USA |
 |
DarioHealth Corp.
DRIO
|
-61.41 | $ 7.59 | 3.48 % | $ 30.2 M |  Israel |
 |
Aspira Women's Health
AWH
|
0.18 | - | -6.19 % | $ 10.5 M | USA |
 |
Celcuity
CELC
|
-176.06 | $ 92.0 | 6.24 % | $ 4.3 B | USA |
 |
Co-Diagnostics
CODX
|
-227.33 | $ 1.4 | 0.68 % | $ 1.86 M | USA |
 |
Check-Cap Ltd.
CHEK
|
120.45 | - | - | $ 9.42 M | Israel |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
DexCom
DXCM
|
30.46 | $ 89.75 | 0.75 % | $ 35 B | USA |
 |
Accelerate Diagnostics
AXDX
|
89.3 | - | -61.36 % | $ 2.46 M | USA |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 1.66 | 0.6 % | $ 7.34 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-656.53 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-147.83 | - | 0.12 % | $ 80.1 M | China |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Soleno Therapeutics
SLNO
|
4.64 | - | - | $ 2.69 B | USA |
 |
Psychemedics Corporation
PMD
|
-36.28 | - | -1.84 % | $ 15.3 M | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
2.49 | $ 163.15 | 0.19 % | $ 12.8 B |  Irlanda |
 |
Syneos Health
SYNH
|
7.63 | - | - | $ 4.46 B | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |
 |
Organovo Holdings
ONVO
|
1259.6 | - | -2.3 % | $ 19.4 M | USA |
 |
IQVIA Holdings
IQV
|
20.91 | $ 236.66 | 0.28 % | $ 40.7 B | USA |
 |
OpGen
OPGN
|
74.14 | - | -16.95 % | $ 1.54 M | USA |
 |
T2 Biosystems
TTOO
|
178.62 | - | -39.35 % | $ 313 K | USA |
 |
Anixa Biosciences
ANIX
|
-72.07 | $ 3.18 | 0.93 % | $ 103 K | USA |
 |
PerkinElmer
PKI
|
3.33 | - | -0.91 % | $ 14.7 B | USA |
 |
Meridian Bioscience
VIVO
|
11.54 | - | - | $ 1.49 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-310.93 | $ 4.47 | 1.36 % | $ 3.52 M | USA |
 |
Quotient Limited
QTNT
|
86.84 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Renalytix AI plc
RNLX
|
425.97 | - | 5.66 % | $ 22.7 M |  Britain |
 |
Natera
NTRA
|
-12.16 | $ 309.93 | 1.04 % | $ 42.4 B | USA |
 |
Myriad Genetics
MYGN
|
-99.46 | $ 3.03 | 0.62 % | $ 281 M | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 15.94 | 0.24 % | $ 2.04 B | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 21.19 | 0.84 % | $ 474 M | USA |
 |
Surmodics
SRDX
|
-9.71 | - | - | $ 608 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.16 | $ 27.29 | 0.51 % | $ 25.9 B | Niderland |
 |
Quidel Corporation
QDEL
|
60.8 | $ 14.3 | 1.75 % | $ 602 M | USA |